Bellevue Funds (Lux) -Bellevue Obesity Solutions I USD - Accumulating/  LU0415392751  /

Fonds
NAV15/05/2024 Diferencia+7.1200 Tipo de beneficio Enfoque de la inversión Sociedad de fondos
584.2400USD +1.23% reinvestment Equity Worldwide Waystone M.Co.(Lux) 

Estrategia de inversión

The Fund invests at least two thirds of the net assets of Bellevue Biotech in a portfolio of carefully chosen shares and other equity securities of companies in the biotechnology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term "biotechnology", the companies within the entire value chain in the biotechnology sector consist especially of companies that prepare, develop, utilise, market and/or sell processes, methods, technologies and products in which organisms, cells or cell constituents are used. Up to one third of the net assets can be invested in debt securities of private and government issuers with various terms and credit ratings. The Fund may engage in derivative transactions in order to achieve an efficient portfolio management, in particular also for hedging purposes.
 

Objetivo de inversión

The Fund invests at least two thirds of the net assets of Bellevue Biotech in a portfolio of carefully chosen shares and other equity securities of companies in the biotechnology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries.
 

Datos maestros

Tipo de beneficio: reinvestment
Categoría de fondos: Equity
Región: Worldwide
Sucursal: Sector Biotechnology
Punto de referencia: MSCI World Healthcare NR
Inicio del año fiscal: 01/07
Última distribución: -
Banco depositario: CACEIS Investor Services Bank
País de origen: Luxembourg
Permiso de distribución: Austria, Germany, Switzerland, United Kingdom, Luxembourg
Gestor de fondo: Christian Lach, Lukas Leu, Oliver Kubli
Volumen de fondo: 36.78 millones  USD
Fecha de fundación: 31/03/2009
Enfoque de la inversión: -

Condiciones

Recargo de emisión: 5.00%
Max. Comisión de administración: 0.90%
Inversión mínima: - USD
Deposit fees: -
Cargo por amortización: 0.00%
Prospecto simplificado: Descargar (Versión para imprimir)
 

Sociedad de fondos

Fondos de empresa: Waystone M.Co.(Lux)
Dirección: 19, rue de Bitbourg, 1273, Luxemburg
País: Luxembourg
Internet: www.waystone.com
 

Activos

Stocks
 
98.45%
Cash and Other Assets
 
1.55%

Países

United States of America
 
66.17%
Denmark
 
9.36%
Switzerland
 
5.82%
United Kingdom
 
5.62%
Germany
 
1.99%
Sweden
 
1.50%
Ireland
 
1.39%
Spain
 
1.18%
Netherlands
 
1.07%
France
 
0.93%
India
 
0.85%
Brazil
 
0.82%
Japan
 
0.78%
China
 
0.75%
Cayman Islands
 
0.22%
Otros
 
1.55%

Sucursales

Pharma/Biotechnology
 
47.55%
Healthcare services
 
21.94%
Healthcare appliances
 
16.04%
Parma, wholesale
 
4.21%
amusement parks
 
1.89%
Cash / other assets
 
1.55%
Leisure articles
 
1.50%
Clothing
 
1.27%
consumer electronics
 
1.15%
Computer Hardware
 
1.07%
Grocery Producers
 
0.93%
Gesundheitswesen/ Informationstechnologie
 
0.90%